HK Stock Market Move | ORBUSNEICH(06929) rose nearly 6% last year, with a 5.49% year-on-year increase in net profit. Revenue reached a five-year high.

date
14:31 13/03/2026
avatar
GMT Eight
Yeju Medical (06929) rose nearly 6%, as of the time of this report, it increased by 5.83% to HK$3.81, with a trading volume of HK$730,900.
ORBUSNEICH (06929) rose nearly 6% as of the time of publication, up 5.83% to 3.81 Hong Kong dollars, with a turnover of 730,900 Hong Kong dollars. In terms of news, ORBUSNEICH released its annual performance for the year ending December 31, 2025. The group achieved operating income of 180 million US dollars during the period, an increase of 9.97% year-on-year, reaching a five-year high. The profit attributable to the owners of the company was 41.899 million US dollars, an increase of 5.49% year-on-year. The announcement stated that gross profit increased by 7.0% from 115 million US dollars for the year ending December 31, 2024 to 122 million US dollars for the same period in 2025, mainly due to an increase in sales volume during the year. In addition, the board of directors proposed a final cash dividend of 12 Hong Kong cents per share, along with a special dividend, making the total cash dividend for the 2025 fiscal year 27 Hong Kong cents per share.